Sam Walter
22 Jan
22Jan

Europe Biopsy Devices Market 2025-2033

According to IMARC Group's report titled "Europe Biopsy Devices Market Size, Share, Trends and Forecast by Procedure Type, Product, Application, Guidance Technique, End User, and Region, 2025-2033", the report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.

How Big is the Europe Biopsy Devices Industry ?

The biopsy devices market in Europe reached USD 629.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,044.27 Million by 2033, exhibiting a growth rate (CAGR) of 5.78% during 2025-2033.

Europe Biopsy Devices Market Trends:

The European market is driven in large part by the increased frequency of cancer and the increasing demands for improved early diagnostic methods. Growing awareness of cancer (such as, breast, and lung and prostate, colorectal cancer) is contributing to the rising growth of the biopsy devices market in Europe. This market expansion has been driven by technological advances of biopsy tools.

For instance, the introduction of vacuum assisted and image guided procedures for biopsies has increased patient comfort and accuracy, reduced time for recovery, and the risk of complications. These advances have also improved patient willingness to have biopsies, and as such, such procedures are being used more and more in various medical specialties. In addition, the growing aging population in Europe is another key factor for market growth.

Get free sample copy of the report:https://www.imarcgroup.com/europe-biopsy-devices-market/requestsample

Europe Biopsy Devices Market Scope and Growth Analysis:

The scope of the biopsy devices market in Europe is broad and covers all the required biopsy techniques, all types of needle biopsies, core biopsies, fine needle aspiration, and vacuum-assisted biopsies. These are used devices in combination with many medical specialties such as oncology, cardiology, and infectious diseases and hence, the market area spans. The main users of the devices are the hospitals, diagnostic center, and biogopsy specialty clinics. In an era marked by the emphasis of early disease detection and targeted therapies toward individual patients, there is a tremendous increase in the requirements for innovative biopsy devices.

In accordance with the present market analysis of the biopsy devices in Europe, a sustained market expansion is expected in the near future of the biopsy devices market in Europe. From the start and above all, cancer disease is afflicting large populations in Europe, like Germany and the UK, France and Italy, a leading force driving their enlargement. These nations are investing more resources into the development of healthcare systems and lung cancer research, driving market demand for next generation biopsy tools. In addition, the increasing adoption of existing technologies such as MRI guided biopsies or ultrasound guided biopsies is increasing the diagnostic reliability further and spurring the expanding use of performance-based contracts in the market. There is a desire among both patients and clinicians to extract the maximum value from medical operations, i.e., the expected risk and duration of recovery that is driving the demand for least invasively performed biopsies.

IMARCs report provides a deep dive into the Europe biopsy devices market analysis, outlining the current trends, underlying market demand, and growth trajectories.

Europe Biopsy Devices Industry Segmentation:

The report has segmented the market into the following categories:

Breakup by Procedure Type:

  • Surgical Biopsy
  • Needle Biopsy

Breakup by Product:

  • Biopsy Guidance Systems
  • Needle Based Biopsy Guns
  • Biopsy Needles
  • Biopsy Forceps
  • Others

Breakup by Application:

  • Breast Biopsy
  • Lung Biopsy
  • Colorectal Biopsy
  • Prostate Biopsy
  • Others

Breakup by Guidance Technique:

  • Ultrasound-guided Biopsy
  • Stereotactic-guided Biopsy
  • MRI-guided Biopsy
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Academic and Research Institutes
  • Others

Breakup by Country:

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others

Competitive Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

Ask Analyst For Customization:https://www.imarcgroup.com/request?type=report&id=3558&flag=C

Other Key Points Covered in the Report:

  • COVID-19 Impact on the Market
  • Porter's Five Forces Analysis
  • Strategic Recommendations
  • Market Dynamics
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape
  • Top Winning Strategies
  • Recent Industry News
  • Key Technological Trends & Development

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us: 

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145

Comments
* The email will not be published on the website.
I BUILT MY SITE FOR FREE USING